# A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

> **NCT02888327** · PHASE1 · COMPLETED · sponsor: **Alios Biopharma Inc.** · enrollment: 68 (actual)

## Conditions studied

- Influenza in Humans

## Interventions

- **DRUG:** AL-794
- **DRUG:** Oseltamivir
- **DRUG:** Digoxin
- **DRUG:** Midazolam
- **DRUG:** Pitavastatin
- **DRUG:** JNJ-63623872

## Key facts

- **NCT ID:** NCT02888327
- **Lead sponsor:** Alios Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-31
- **Primary completion:** 2017-05-30
- **Final completion:** 2017-05-30
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888327, "A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02888327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*